Ado Pharmaceuticals Private Limited
About Ado Pharmaceuticals Private Limited
Data last updated:
Ado Pharmaceuticals Private Limited is a private limited company based in Mohali, Punjab, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 09 February 2022.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24290PB2022PTC055199.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹7 Lakh. It is led by directors Arti Saroha and Arun Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. E – 58 Industrial Area Phase – 8 Sas Nagar, Mohali, Punjab, India – 160055.
As per the financials filed for FY 2024, the company reported a revenue of ₹19.12 Lakh, a growth of 47% compared to the previous year. For the same year it recorded a net loss of ₹6.85 Lakh (net margin -35.8%) and EBITDA of -₹2.29 Lakh (EBITDA margin -12%).
Company details
Contact details
Ado Pharmaceuticals Private Limited's registered office is in Mohali, Punjab.
- Registered AddressPlot No. E – 58 Industrial Area Phase – 8 Sas Nagar, Mohali, Punjab, India – 160055
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ado Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ado Pharmaceuticals Private Limited, buy the company report.
Financials of Ado Pharmaceuticals Private Limited
FY 2025 filings availableAdo Pharmaceuticals Private Limited reported revenue of ₹19.12 Lakh (up 47% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 47% in the latest year. EBITDA rose 33% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹2.29 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹6.85 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -12% | ||
| Net Profit Margin | -35.8% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Ado Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ado Pharmaceuticals Private Limited
Ado Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arti Saroha | Director | 09 Feb 2022 | 4 Years 8 Months | Current |
| Arun Singh | Director | 09 Feb 2022 | 4 Years 8 Months | Current |
Peer comparison
Ado Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sashwat Pharmaceuticals Private Limited | ₹19.16 Lakh (FY 2025) | -82.0% | New Delhi, Delhi, India | |||
| Ado Pharmaceuticals Private Limitedthis company | ₹19.12 Lakh (FY 2024) | -₹6.85 Lakh | -35.8% | 47.0% | Mohali, Punjab, India | |
| Arvikha Pharmaceuticals Private Limited | ₹19.09 Lakh (FY 2025) | 15.0% | Kolkata, West Bengal, India | |||
| Dablap Pharmaceuticals Private Limited | ₹19.07 Lakh (FY 2025) | 38.0% | Delhi, India | |||
| Eligens Pharmaceuticals Private Limited | ₹19.06 Lakh (FY 2025) | 29.0% | Lucknow, Uttar Pradesh, India | |||
| Pinakin Pharmaceuticals Private Limited | ₹19.03 Lakh (FY 2024) | 3.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Ado Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ado Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ado Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Ado Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Ado Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Arti Saroha was appointed as Director on 09 Feb 2022.
Frequently asked questions
Ado Pharmaceuticals is an active private limited company based in Mohali, Punjab, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 09 February 2022 (4+ years old) and is registered under CIN U24290PB2022PTC055199.
Ado Pharmaceuticals has 2 current directors:
- Arti Saroha - Director
- Arun Singh - Director
The latest financial statements of Ado Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Ado Pharmaceuticals is U24290PB2022PTC055199. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ado Pharmaceuticals was incorporated on 09 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Ado Pharmaceuticals by revenue are Sashwat Pharmaceuticals Private Limited, Arvikha Pharmaceuticals Private Limited, Dablap Pharmaceuticals Private Limited, Eligens Pharmaceuticals Private Limited, Pinakin Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Arti Saroha was appointed as Director on 09 Feb 2022. Arun Singh was appointed as Director on 09 Feb 2022.
The registered office of Ado Pharmaceuticals is at Plot No. E – 58 Industrial Area Phase – 8 Sas Nagar, Mohali, Punjab, India – 160055.
Ado Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Ado Pharmaceuticals can be reached at its registered office: Plot No. E – 58 Industrial Area Phase – 8 Sas Nagar, Mohali, Punjab, India – 160055.
Ado Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Chandigarh.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
